These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 38035095)

  • 1. Vaccine development against tuberculosis before and after Covid-19.
    Kaufmann SHE
    Front Immunol; 2023; 14():1273938. PubMed ID: 38035095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development.
    Hu Z; Lu SH; Lowrie DB; Fan XY
    Front Immunol; 2022; 13():895020. PubMed ID: 35812383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. End-point definition and trial design to advance tuberculosis vaccine development.
    Garcia-Basteiro AL; White RG; Tait D; Schmidt AC; Rangaka MX; Quaife M; Nemes E; Mogg R; Hill PC; Harris RC; Hanekom WA; Frick M; Fiore-Gartland A; Evans T; Dagnew AF; Churchyard G; Cobelens F; Behr MA; Hatherill M
    Eur Respir Rev; 2022 Jun; 31(164):. PubMed ID: 35675923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New vaccines against tuberculosis].
    Kaufmann SHE
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jan; 63(1):56-64. PubMed ID: 31784764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in protein subunit vaccines against tuberculosis.
    Zhang Y; Xu JC; Hu ZD; Fan XY
    Front Immunol; 2023; 14():1238586. PubMed ID: 37654500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A century of attempts to develop an effective tuberculosis vaccine: Why they failed?
    Soleimanpour S; Yaghoubi A; Sadat Seddighinia F; Rezaee SAR
    Int Immunopharmacol; 2022 Aug; 109():108791. PubMed ID: 35487086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Jia Q; Masleša-Galić S; Nava S; Horwitz MA
    mBio; 2022 Jun; 13(3):e0068722. PubMed ID: 35642945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis Vaccine Development: Progress in Clinical Evaluation.
    Sable SB; Posey JE; Scriba TJ
    Clin Microbiol Rev; 2019 Dec; 33(1):. PubMed ID: 31666281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-Based Vaccines for Tuberculosis.
    Gong W; Pan C; Cheng P; Wang J; Zhao G; Wu X
    Front Immunol; 2022; 13():830497. PubMed ID: 35173740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel vaccination strategies and approaches against human tuberculosis.
    Méndez-Samperio P
    Scand J Immunol; 2019 Aug; 90(2):e12774. PubMed ID: 31054193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
    Coppola M; Ottenhoff TH
    Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology.
    Kaufmann SHE
    Front Immunol; 2020; 11():316. PubMed ID: 32174919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards the development of subunit vaccines against tuberculosis: The key role of adjuvant.
    Duong VT; Skwarczynski M; Toth I
    Tuberculosis (Edinb); 2023 Mar; 139():102307. PubMed ID: 36706503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging the gaps to overcome major hurdles in the development of next-generation tuberculosis vaccines.
    Kim H; Choi HG; Shin SJ
    Front Immunol; 2023; 14():1193058. PubMed ID: 37638056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis.
    Scriba TJ; Netea MG; Ginsberg AM
    Semin Immunol; 2020 Aug; 50():101431. PubMed ID: 33279383
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.